Samuel Kerama
Medical Products & Health Technologies Directorate
Department of Product Safety
Clinical Trials Division
Pharmacy and Poisons Board, Kenya
Dr. Samuel Kerama is a Principal Regulatory Officer at the Kenya Pharmacy and Poisons Board (PPB). He is currently in charge of the Clinical Trials Oversight Division.
His responsibilities include reviewing Clinical Trial Protocols and applications, performing Good Clinical Practice (GCP) inspections, and performing good manufacturing practice (GMP) inspections for medicines, including investigational products. He has been involved in developing Regulatory instruments including for GCP inspection, Good Regulatory Practices (GRP) and safe handling of Pharmaceutical Waste.
Regionally, he serves as a Resource person to the Africa Medicines Agency (AMA) as a GMP inspector, as well as a Medicines Dossier assessor for the East Africa Community (EAC) and Intergovernmental Authority on Development (IGAD) on Quality and Bioequivalence.
He holds a Master of Pharmacy degree (Clinical Pharmacy) from the University of Nairobi, and a Master of Science in Biotechnology, Innovation, and Regulatory Sciences (BIRS) from Purdue University. He is a current PhD student at Purdue University.
He is passionate about Medicine safety, Human dignity, and the safety of Clinical trial participants and loves sports.
